FDA clears medical device developed by OHSU and AMES Technology, Inc. for muscle and joint rehabilitation

The Food and Drug Administration today granted 510(k) clearance to a muscle and joint rehabilitation medical device developed by OHSU Scientist Dr. Paul Cordo, Ph.D., and AMES Technology, Inc.

AMES is an Oregon Health & Science University spinoff company established to transform Dr. Cordo’s OHSU research findings into a rehabilitation medical device for use in hospitals and clinics. Today’s FDA clearance allows AMES to market and sell the device. AMES anticipates delivering the device to hospitals and clinics in early 2014. The typical patient population that possibly receive treatment with an AMES Device would include stroke victims and patients with partial injuries to the spinal cord.

CONTINUE HERE:

This entry was posted in Chronic Spinal Cord Injury Research, Regenerative Medicine, Rehabilitation, Spinal Research and tagged . Bookmark the permalink.